In the present experiments, we show that CSF1, but not IL-34, is up-regulated in the spinal cord of SOD1G93A mice and that the treatment with GW2580, a selective CSFR1 inhibitor, attenuates microglial cell expansion and slows the progression of ALS disease. The gene discussed is IL34; the disease is amyotrophic lateral sclerosis.